IL9 and neoplasm: According to existing literature, IL-9 binds to heterodimer receptors, activating the Janus kinase(JAK)-STAT, insulin receptor substrates(IRS), and MAPK signaling pathways, thereby directly stimulating tumor cell proliferation (123).